参考文献/References:
[1] STONE P H, LIBBY P, BODEN W E. Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management-the plaque hypothesis: a narrative review[J]. JAMA Cardiology, 2023, 8(2): 192-201.
[2] DU Yunhui, ZHANG Shihan, YU Haicun, et al. Autoantibodies against β1-adrenoceptor exaggerated ventricular remodeling by inhibiting CTRP9 expression[J]. Journal of the American Heart Association, 2019, 8(4): e010475.
[3] XIA Peng, CHEN Jingrui, LIU Yuening, et al. Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2-mediated activation of forkhead box O1[J]. Journal of Biological Chemistry, 2020, 295(13): 4265-4276.
[4] VISHNOI A, RANI S. MiRNA biogenesis and regulation of diseases: an updated overview[J]. Methods in Molecular Biology, 2023, 2595: 1-12.
[5] 刘龙梅, 石懿玉, 杨霞, 等. 急性缺氧诱导小鼠心肌细胞微小RNA-34a 升高和凋亡实验研究[J]. 陕西医学杂志, 2023, 52(10): 1295-1298, 1303. LIU Longmei, SHI Yiyu, YANG Xia, et al. Experimental study of microRNA-34a elevation and apoptosis in mouse cardiomyocytes induced by acute hypoxia[J]. Shaanxi Medical Journal, 2023, 52(10): 1295-1298, 1303.
[6] 李敏, 陈霞, 何偲, 等. 缺血性心力衰竭患者血清miR-34 表达水平与心室重构和预后的相关性分析[J]. 现代检验医学杂志, 2023, 38(4): 67-71. LI Min, CHEN Xia, HE Si, et al. Correlation between serum miR-34 expression and ventricular remodeling and prognosis in patients with ischemic heart failure[J]. Journal of Modern Laboratory Medicine, 2023, 38(4): 67-71.
[7] ZUO Wei, TIAN Ran, CHEN Qian, et al. MiR-330-5p inhibits NLRP3 inflammasome-mediated myocardial ischaemia-reperfusion injury by targeting TIM3[J]. Cardiovascular Drugs and Therapy, 2021, 35(4): 691-705.
[8] SHI Yan, HOU Shuai. Protective effects of metformin against myocardial ischemia-reperfusion injury via AMPK-dependent suppression of NOX4[J]. Molecular Medicine Reports, 2021, 24(4): 712.
[9] 陈悦, 李青, 吕文君, 等. miR-206-3p 在缺氧复氧诱导的心肌细胞损伤中的作用及机制的研究[J]. 解剖科学进展, 2022, 28(05):543-546, 550. CHEN Yue, LI Qing, L? Wenjun, et al. Effect of miR-206-3p in H9C2 cardiomyocyte injury induced by hypoxia/reoxygenation[J]. Progress of Anatomical Sciences, 2022, 28(05): 543-546, 550.
[10] JIN Yongping, NI Shimao. MiR-496 remedies hypoxia reoxygenation-induced H9C2 cardiomyocyte apoptosis via hook3-targeted PI3k/Akt/mTOR signaling pathway activation[J]. Journal of Cellular Biochemistry, 2020,121(1): 698-712.
[11] ZHAI Changlin, TANG Guanmin, QIAN Gang, et al. MicroRNA-98 attenuates cardiac ischemia-reperfusion injury through inhibiting DAPK1 expression[J]. IUBMB Life, 2019, 71(2): 166-176.
[12] CHEN Jiansheng, CHEN Taoliang, ZHU Yubo, et al.CircPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma[J]. Journal of Experimental & Clinical Cancer Research, 2019, 38(1): 398.
[13] WANG Yuanyong, XU Rongjian, ZHANG Dongyang,et al. Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression[J]. Translational Lung Cancer Research,2019, 8(6): 862-875.
[14] HAN Dong, WANG Yongjun, WANG Yabin, et al. The tumor-suppressive human circular RNA circITCH sponges miR-330-5p to ameliorate Doxorubicininduced cardiotoxicity through upregulating SIRT6,survivin, and SERCA2a[J]. Circulation Research, 2020,127(4): e108-e125.
[15] 梁雨亭, 刘文秀, 塔娜, 等. NOX4 在心血管疾病中的研究进展[J]. 心血管病学进展, 2019, 40(2): 212-215. LIANG Yuting, LIU Wenxiu, TA Na, et al. NOX4 in cardiovascular diseases[J]. Advances in Cardiovascular Diseases, 2019, 40(2): 212-215.
[16] YU Weimin, LI Siqi, WU Haixia, et al. Endothelial Nox4 dysfunction aggravates atherosclerosis by inducing endoplasmic reticulum stress and soluble epoxide hydrolase[J]. Free Radical Biology & Medicine, 2021, 164: 44-57.
[17] XIAO Lili, GU Yulei, REN Gaofei, et al. MiRNA-146a mimic inhibits NOX4/P38 signalling to ameliorate mouse myocardial ischaemia reperfusion (I/R) injury[J]. Oxidative Medicine and Cellular Longevity,2021, 2021: 6366254.